Becton Dickinson and Co
NYSE:BDX

  • LAST PRICE
    225.1500
  • TODAY'S CHANGE (%)
    -2.0200 (-0.8892%)
  • Bid / Lots
    224.5700/ 1
  • Ask / Lots
    225.9200/ 1
  • Open / Previous Close
    227.0000 / 227.1700
  • Day Range
    223.4930
    228.3100
  • 52 Week Range
    218.7500
    249.8900
  • Volume
    1,965,697

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
BDX
Becton Dickinson and Co
65.1B
37.9x
+9.57%
IDXX
IDEXX Laboratories Inc
34.5B
40.6x
+18.62%
DXCM
Dexcom Inc
29.6B
46.3x
---
BAX
Baxter International Inc
16.3B
72.3x
---
ZBH
Zimmer Biomet Holdings Inc
22.4B
21.4x
---
STE
STERIS plc
21.7B
36.2x
+9.33%
As of 2024-11-16

Company Information

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring solutions and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Contact Information

Headquarters
One Becton DriveFRANKLIN LAKES, NJ, United States 07417-1880
Phone
201-847-6800
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer
Thomas Polen
Chief Financial Officer, Executive Vice President
Christopher Delorefice
Chief People Officer, Executive Vice President
Shana Neal
Executive Vice President, President, North America, Chief Marketing Officer
Antoine Ezell
Executive Vice President, General Counsel
Michelle Quinn

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$65.1B
Revenue (TTM)
$20.2B
Shares Outstanding
289.0M
Dividend Yield
1.85%
Annual Dividend Rate
4.1600 USD
Ex-Dividend Date
12-09-24
Pay Date
12-31-24
Beta
0.43
EPS
$5.94
Book Value
$89.64
P/E Ratio
37.9x
Price/Sales (TTM)
3.2
Price/Cash Flow (TTM)
16.2x
Operating Margin
12.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.